The goals of Project 2 are to develop a detailed picture of human disease-associated RecQ helicase protein function, and to use this information to delineate the role of these RecQ helicases in human tumor cell proliferation, survival and the response to chemotherapy. In research to date we have focused on functional analyses of the human Werner syndrome protein WRN. In the proposed research we extend these analyses to encompass all three disease-associated human RecQ helicases, the WRN, BLM and RECQL4 proteins associated with the heritable deficiency/genetic instability/cancer predisposition syndromes Werner syndrome (WRN), Bloom syndrome (BLM) and Rothmund-Thomson (RTS) syndrome, respectively.
Aim 1. Develop a comprehensive proteomic description of the human disease-associated WRN, BlM and RECQl4 human RecQ helicases. We will identify functionally important RecQ helicase protein associations and post-translational modifications (PTM's) by using quantitative affinity purification mass spectrometry, shRNA-mediated epistatic interaction mapping and functional analyses of post-translational modification (PTM) site mutants.
Aim 2. Determine functional requirement for WRN, BlM and RECQL4 in DNA metabolism. We will determine the role of each of these RecQ helicases in DNA replication, translesion DNA synthesis (TLS), homology-dependent recombination (HDR) and DNA break repair using high resolution assays.
Aim 3. Determine functional redundancy among WRN, BlM and RECQL4 in DNA metabolism, and clinically relevant synthetic interactions with additional genes/proteins, drugs or small molecules. We will identify unique and redundant functions of the 'disease-associated human RecQ helicases, and synthetic interactions between disease-associated human RecQ helicases, their interacting proteins, and chemotherapeutic agents, drugs or small molecules that can beused to selectively kill RecQ-deficient human tumors.
The human RecQ helicase proteins maintain genomic stability and protect against DNA damage and DNA metabolic errors. The proposed research will provide insight into the functions of these critical proteins in human cells, and how RecQ function is related to cancer risk and the response to cancer chemotherapy.
Orozco, Javier I J; Knijnenburg, Theo A; Manughian-Peter, Ayla O et al. (2018) Epigenetic profiling for the molecular classification of metastatic brain tumors. Nat Commun 9:4627 |
Schmitt, Michael W; Pritchard, Justin R; Leighow, Scott M et al. (2018) Single-Molecule Sequencing Reveals Patterns of Preexisting Drug Resistance That Suggest Treatment Strategies in Philadelphia-Positive Leukemias. Clin Cancer Res 24:5321-5334 |
Mikheev, Andrei M; Mikheeva, Svetlana A; Severs, Liza J et al. (2018) Targeting TWIST1 through loss of function inhibits tumorigenicity of human glioblastoma. Mol Oncol 12:1188-1202 |
Lee, Su-In; Celik, Safiye; Logsdon, Benjamin A et al. (2018) A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia. Nat Commun 9:42 |
Salk, Jesse J; Schmitt, Michael W; Loeb, Lawrence A (2018) Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations. Nat Rev Genet 19:269-285 |
Davis, Luther; Zhang, Yinbo; Maizels, Nancy (2018) Assaying Repair at DNA Nicks. Methods Enzymol 601:71-89 |
Yu, Ming; Heinzerling, Tai J; Grady, William M (2018) DNA Methylation Analysis Using Droplet Digital PCR. Methods Mol Biol 1768:363-383 |
Knijnenburg, Theo A; Wang, Linghua; Zimmermann, Michael T et al. (2018) Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas. Cell Rep 23:239-254.e6 |
Poston, Jacqueline N; Becker, Pamela S (2017) Controversies Regarding Use of Myeloid Growth Factors in Leukemia. J Natl Compr Canc Netw 15:1551-1557 |
Kamath-Loeb, Ashwini S; Zavala-van Rankin, Diego G; Flores-Morales, Jeny et al. (2017) Homozygosity for the WRN Helicase-Inactivating Variant, R834C, does not confer a Werner syndrome clinical phenotype. Sci Rep 7:44081 |
Showing the most recent 10 out of 137 publications